Markets & news

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 478105.6 Face Value (Rs.) : 1 House : Ipca Laboratories
BSECurrent Price (Rs.) 1881.70Change (Rs.)148.05 (+8.54 %)
PREV CLOSE (Rs.) 1733.65
OPEN PRICE (Rs.) 1800.35
BID PRICE (QTY) 1881.40 (21)
OFFER PRICE (QTY) 1884.20 (84)
VOLUME 348118
TODAY'S LOW / HIGH (Rs.)1800.35 1945.00
52 WK LOW / HIGH (Rs.)1252.95 1941.4
NSECurrent Price (Rs.) 1884.60Change (Rs.)150.4 (+8.67 %)
PREV CLOSE( Rs. ) 1734.20
OPEN PRICE (Rs.) 1805.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6964883
TODAY'S LOW / HIGH(Rs.) 1805.90 1945.10
52 WK LOW / HIGH (Rs.)1251.6 1944.9
GO

Financial Ratios

Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
44.98  
29.08  
21.57  
18.58  
34.85  
   CEPS(Rs)
63.44  
46.72  
34.94  
29.70  
45.07  
   DPS(Rs)
6.00  
4.00  
4.00  
4.00  
4.00  
   Book NAV/Share(Rs)
317.72  
273.78  
249.53  
230.27  
215.41  
   Tax Rate(%)
24.24  
30.38  
37.20  
33.99  
19.79  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
20.26  
18.69  
16.41  
14.47  
21.57  
   EBIT Margin(%)
17.12  
13.64  
12.76  
12.71  
19.67  
   Pre Tax Margin(%)
16.30  
12.65  
10.94  
11.94  
19.48  
   PAT Margin (%)
12.35  
8.81  
6.87  
7.88  
15.63  
   Cash Profit Margin (%)
16.68  
13.26  
11.50  
12.07  
19.61  
Performance Ratios
 
 
 
 
 
   ROA(%)
9.89  
6.90  
5.37  
6.06  
13.31  
   ROE(%)
15.88  
11.86  
8.70  
8.70  
17.92  
   ROCE(%)
19.41  
15.27  
13.10  
11.71  
20.46  
   Asset Turnover(x)
0.80  
0.78  
0.78  
0.77  
0.85  
   Sales/Fixed Asset(x)
1.31  
1.28  
1.35  
1.54  
1.68  
   Working Capital/Sales(x)
2.37  
2.50  
2.42  
1.85  
1.96  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.76  
0.78  
0.74  
0.65  
0.60  
   Receivable days
73.75  
72.89  
63.37  
55.52  
53.92  
   Inventory Days
100.11  
102.72  
99.83  
105.25  
108.09  
   Payable days
131.14  
121.11  
102.19  
86.04  
111.16  
Valuation Parameters
 
 
 
 
 
   PER(x)
35.64  
51.63  
57.39  
43.62  
30.45  
   PCE(x)
25.27  
32.13  
35.44  
27.28  
23.55  
   Price/Book(x)
5.05  
5.48  
4.96  
3.52  
4.93  
   Yield(%)
0.37  
0.27  
0.32  
0.49  
0.38  
   EV/Net Sales(x)
4.25  
4.39  
4.24  
3.25  
4.67  
   EV/Core EBITDA(x)
18.93  
21.43  
22.44  
19.11  
19.63  
   EV/EBIT(x)
24.71  
32.03  
33.05  
25.41  
23.60  
   EV/CE(x)
4.65  
4.73  
4.21  
2.76  
4.33  
   M Cap / Sales
4.24  
4.28  
4.10  
3.31  
4.64  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
7.89  
16.11  
23.50  
7.03  
7.45  
   Core EBITDA Growth(%)
18.35  
25.78  
37.28  
-23.51  
-14.35  
   EBIT Growth(%)
35.49  
23.95  
23.94  
-30.82  
-18.15  
   PAT Growth(%)
51.28  
48.81  
7.58  
-46.00  
-20.71  
   EPS Growth(%)
54.69  
34.77  
16.13  
-46.69  
-61.22  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.09  
0.19  
0.22  
0.25  
0.14  
   Current Ratio(x)
2.76  
2.50  
2.35  
2.87  
3.03  
   Quick Ratio(x)
1.58  
1.43  
1.30  
1.91  
1.77  
   Interest Cover(x)
20.88  
13.88  
6.99  
16.47  
102.40  
   Total Debt/Mcap(x)
0.02  
0.03  
0.04  
0.07  
0.03  
BACK TO TOP